Specialized Efficacy Models
Specialized Oncology Models
Other Therapeutic Areas

Other Therapeutic Areas

Allergy & Respiratory

  • Peanut allergy model
  • Atopic asthma (multiple models)
  • Rapid Hookworm-induced chronic obstructive pulmonary disease (COPD)

Cardiovascular, Metabolic and Endocrine Diseases

  • Lipidic disorder (Syrian Gold hamsters)
  • Type II Diabetes
  • Myocardial infarction
  • Arterial restenosis

Gastrointestinal, Hepatology & Renal

  • Dss-induced colitis
  • TNBS-induced colitis
  • T cell-induced colitis
  • Salmonella-induced colitis
  • Cisplatin-induced nephrotoxicity
  • Liver cirrhosis

Infectious Diseases

  • Viral
    • Influenza A
    • Lymphocytic choriomeningitis virus (LCMV)
    • Vesicular Stomatitis Virus (VSV)
    • Murine cytomegalovirus (MCMV)
    • Vaccinia Virus
  • Bacterial
    • Listeria monocytogenes
    • Legionella pneumophila
    • Escherichia coli
  • Parasitic
    • Heligmosomoides polygyrus
    • Nippostrongylus brasiliensis
  • Protozoan
    • Leishmania major

Inflammation & Autoimmune diseases

  • Ear topical inflammation
  • Experimental autoimmune myocarditis
  • Experimental autoimmune encephalomyelitis
  • Rheumatoid arthritis (rat)
  • Collagen-induces arthritis
  • Collagen antibody-induced arthritis

Dermal

  • Incisional wound healing
  • Excisional wound healing
  • Split thickness wound healing
  • Keratectomy and re-epitheliazation model
  • Laser PR keratectomy
  • Third degree skin burn (w/without pseudomonas)

Ophthalmology

  • ERG (Electroretinography)
  • Partial Iridectomy
  • Heptanol corneal ulcer

Insymbiosis is constantly working to offer new assays and specific assays can be used or developed based on client needs.

Please see our Specialized Efficacy Model brochure for more details or Contact Us.